MARINUS PHARMACEUTICALS, INC. — Form D/A

MARINUS PHARMACEUTICALS, INC. of Radnor, PA, a company, filed a Form D amendment with the SEC on 2013-07-09. The offering totals $22.3M, of which $21.8M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (39)

Showing 25 of 39 people.

NameRoleLocation
Stephen M Bloch, M.D.DirectorNew Haven, CT
Christopher M CashmanDirectorBedford, MA
Anton M GopkaDirectorNew Haven, CT
Timothy M MaylebenDirectorAnn Arbor, MI
Anand T Mehra, M.D.DirectorNew Haven, CT
Harry M PennerDirectorNew Haven, CT
Harry T ReinDirectorNew Haven, CT
Nicole T VitulloDirectorNew Haven, CT
Christopher M CashmanExecutive OfficerBedford, MA
Charles E AustinDirectorCannelton, IN
Anand MehraDirectorWayne, PA
Stephen BlochDirectorParsippany, NJ
Tim M MaylebenDirectorRadnor, PA
Nicole E VitulloDirectorRadnor, PA
Michael R DoughertyDirectorRadnor, PA
Steven E PfanstielExecutive OfficerRadnor, PA
Saraswathy M Nochur, Ph.D.DirectorRadnor, PA
Elan R EzicksonDirectorRadnor, PA
Martha E Manning, Esq.Executive OfficerRadnor, PA
Joseph E Hulihan, M.D.Executive OfficerRadnor, PA
Scott Braunstein, M.D.DirectorRadnor, PA
Scott Braunstein, M.D.Executive OfficerRadnor, PA
Santiago E Arroyo, M.D., Ph.D.DirectorRadnor, PA
Seth HZ FischerDirectorRadnor, PA
Kenneth ShawExecutive OfficerScottsdale, AZ

Other filings by this issuer (4)

FiledFormOfferingSold
2022-04-04D$1.2M$1.2M
2019-12-19D$30.0M$30.0M
2012-12-18D$21.2M$11.4M
2009-04-22D$20.4M

More